Our history

GL Pharma was formed out of a merger of the two pharmaceutical companies Gerot and Lannacher and has a history of more than 70 years.

We develop and manufacture both branded and complex generic medicines to help healthcare professionals across the world manage a broad range of conditions.

GL Pharma UK was established in 2021 to support the NHS in providing high quality healthcare to its patients in the most affordable way.

Martin Bartenstein

CEO

Ilse Bartenstein

CEO

1947/48

Foundation of Lannacher Heilmittel in Lannach/Graz and Gerot Pharmazeutika in Vienna

1966

Leopold and Hannelore Bartenstein take over Lannacher Heilmittel

1997

Lannacher Heilmittel acquires Gerot Pharmazeutika

2003

Start of operation in the state-of-the-art solid forms production site Lannach

2009

Lannacher and Gerot merge under the brand GL Pharma in G.L. Pharma

2021

Formation of GL Pharma UK located on the outskirts of the Cambridge life sciences cluster

Markets

Our products can be found in more than 50 markets worldwide. GL Pharma has 16 distribution structures in Europe and a subsidiary in Central America.

Headcount

~1.100 employees

Revenues

~€247 M. (2022) revenue, €363 M. (2022) including Genericon Pharma

Production Volume

~4.670 M. single doses

GL Pharma at a glance